BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16886684)

  • 1. Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis.
    Sieg J; Sieg A; Dreyhaupt J; Schmidt-Gayk H
    Anticancer Res; 2006; 26(4A):2729-33. PubMed ID: 16886684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
    Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis.
    Choi YJ; Kim YH; Cho CH; Kim SH; Lee JE
    World J Gastroenterol; 2015 Aug; 21(29):8868-77. PubMed ID: 26269676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation.
    Savoie MB; Paciorek A; Zhang L; Van Blarigan EL; Sommovilla N; Abrams D; Atreya CE; Bergsland EK; Chern H; Kelley RK; Ko A; Laffan A; Sarin A; Varma MG; Venook AP; Van Loon K
    J Gastrointest Cancer; 2019 Dec; 50(4):769-779. PubMed ID: 30058032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of very low serum 25-hydroxyvitamin D
    Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
    Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.
    McCullough ML; Zoltick ES; Weinstein SJ; Fedirko V; Wang M; Cook NR; Eliassen AH; Zeleniuch-Jacquotte A; Agnoli C; Albanes D; Barnett MJ; Buring JE; Campbell PT; Clendenen TV; Freedman ND; Gapstur SM; Giovannucci EL; Goodman GG; Haiman CA; Ho GYF; Horst RL; Hou T; Huang WY; Jenab M; Jones ME; Joshu CE; Krogh V; Lee IM; Lee JE; Männistö S; Le Marchand L; Mondul AM; Neuhouser ML; Platz EA; Purdue MP; Riboli E; Robsahm TE; Rohan TE; Sasazuki S; Schoemaker MJ; Sieri S; Stampfer MJ; Swerdlow AJ; Thomson CA; Tretli S; Tsugane S; Ursin G; Visvanathan K; White KK; Wu K; Yaun SS; Zhang X; Willett WC; Gail MH; Ziegler RG; Smith-Warner SA
    J Natl Cancer Inst; 2019 Feb; 111(2):158-169. PubMed ID: 29912394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology.
    Väyrynen JP; Mutt SJ; Herzig KH; Väyrynen SA; Kantola T; Karhu T; Karttunen TJ; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A
    Sci Rep; 2016 Nov; 6():36519. PubMed ID: 27819306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis.
    Huang D; Lei S; Wu Y; Weng M; Zhou Y; Xu J; Xia D; Xu E; Lai M; Zhang H
    Clin Nutr; 2020 Aug; 39(8):2525-2538. PubMed ID: 31784301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating vitamin D and colorectal adenomas in Japanese men.
    Takahashi R; Mizoue T; Otake T; Fukumoto J; Tajima O; Tabata S; Abe H; Ohnaka K; Kono S
    Cancer Sci; 2010 Jul; 101(7):1695-700. PubMed ID: 20507319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
    Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
    Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
    Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis.
    Jacobs ET; Hibler EA; Lance P; Sardo CL; Jurutka PW
    Int J Cancer; 2013 Dec; 133(12):2980-8. PubMed ID: 23754630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Serum Vitamin D: A Surrogate Marker for Advanced Colon Adenoma?
    Ahmad II; Trikudanathan G; Feinn R; Anderson JC; Nicholson M; Lowe S; Levine JB
    J Clin Gastroenterol; 2016 Sep; 50(8):644-8. PubMed ID: 26905602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps.
    Adams SV; Newcomb PA; Burnett-Hartman AN; White E; Mandelson MT; Potter JD
    Nutr Cancer; 2011; 63(3):319-26. PubMed ID: 21432725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence.
    Jacobs ET; Alberts DS; Benuzillo J; Hollis BW; Thompson PA; Martínez ME
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):752-6. PubMed ID: 17223551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vitamin D levels correlate with the presence and histological grading of colorectal adenomas in peri and postmenopausal women.
    Marques da Costa P; Martins I; Neves J; Cortez-Pinto H; Velosa J
    Clin Nutr; 2019 Jun; 38(3):1390-1397. PubMed ID: 29961649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk.
    Levine AJ; Harper JM; Ervin CM; Chen YH; Harmon E; Xue S; Lee ER; Frankel HD; Haile RW
    Nutr Cancer; 2001; 39(1):35-41. PubMed ID: 11588900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study.
    Fedirko V; Bostick RM; Goodman M; Flanders WD; Gross MD
    Am J Epidemiol; 2010 Sep; 172(5):489-500. PubMed ID: 20650953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
    Ng K; Sargent DJ; Goldberg RM; Meyerhardt JA; Green EM; Pitot HC; Hollis BW; Pollak MN; Fuchs CS
    J Clin Oncol; 2011 Apr; 29(12):1599-606. PubMed ID: 21422438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy and vitamin D supplement use are determinants of serum 25-hydroxyvitamin D levels during the first six months after colorectal cancer diagnosis.
    Wesselink E; Bours MJL; de Wilt JHW; Aquarius M; Breukink SO; Hansson B; Keulen ETP; Kok DE; van den Ouweland J; van Roekel EH; Snellen M; Winkels R; Witkamp RF; van Zutphen M; Weijenberg MP; Kampman E; van Duijnhoven FJB
    J Steroid Biochem Mol Biol; 2020 May; 199():105577. PubMed ID: 31917319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.